Description

• Feline sulfonamide in dosage form of tablets.



• Treats a wide range of respiratory, genitourinary tract, enteric and soft-tissue infections.



• Clinical or experimental efficacy has been demonstrated against infections caused by Streptococcus, Staphylococcus, Escherichia, Salmonella, Klebsiella, Proteus or Shigella organisms sensitive to sulfadimethoxine.

• Treatment of tonsillitis, pustular dermatitis, pharyngitis, anal gland infections, bronchitis, abscesses, pneumonia, wound infections, cystitis, bacterial enteritis, canine salmonellosis, metritis, bacterial enteritis associated with coccidiosis in dogs, and pyometra caused by Staphylococcus, Escherichia, Salmonella, Klebsiella, Proteus or Shigella organisms sensitive to sulfadimethoxine.

• Low-dosage, rapidly absorbed, long-acting sulfonamide.



• Effective for a wide range of bacterial infections commonly encountered in cats.



• Plasma protein binding of sulfadimethoxine is very high, providing a blood reservoir of the drug and maintaining higher blood levels than most other long-acting sulfonamides.



• Single, comparatively low dose gives rapid and sustained therapeutic blood levels.



• Has relatively high solubility at normal kidney pH, precluding possibility of precipitation and crystalluria.



• Oral formulations can be utilized for maintenance therapy.

• For ease of administration in animals of varying weights, 3 tablet sizes (125 mg, 250 mg and 500 mg) are provided.



• Subsequent doses should be given at 24-hour intervals.



• Cats should receive 25 mg/lb of body weight (55 mg/kg) as an initial dose, followed by 12.5 mg/lb (27.5 mg/kg) of body weight every 24 hours thereafter.

• During treatment period, make certain that animals maintain adequate water intake.



• If animals show no improvement within 2 to 3 days, diagnosis should be re-evaluated.



• Store at room temperature.



• Federal law restricts use by or on order of a licensed veterinarian.